by Stephen Manobiano | Jun 30, 2026 | AI, Commercialization, Marketing, news, Sales
Every instrument vendor, every kit company, and every informatics platform now claims to be “AI-powered.” Which means the phrase has stopped doing any commercial work for you. Technical buyers have heard it enough times that it now triggers skepticism instead of...
by Stephen Manobiano | Jun 30, 2026 | Commercialization, Marketing, news, Sales
Cell biology is the largest single technology segment in the life science tools market, and “cell biology” is exactly the kind of label that flattens two very different sales motions into one generic pitch. Single-cell sequencing resolves heterogeneity inside a...
by Stephen Manobiano | Jun 29, 2026 | Founders and Business Leaders, news
Spatial transcriptomics, spatial proteomics, and mass spectrometry imaging are converging fast. Researchers can now map gene and protein expression directly inside intact tissue, something no bulk, homogenized sample could ever show them. That’s a genuine scientific...
by Stephen Manobiano | Jun 26, 2026 | CRM best practices, Founders and Business Leaders, Marketing, Sales
20 Questions Founders and CEOs Ask About Sales, Marketing, CRM, HubSpot, and Growth in Life Science Markets Commercializing a reagent or kit company is difficult because the market is crowded, technical, price-sensitive, and often dominated by established brands and...
by Stephen Manobiano | Jun 18, 2026 | business development, Founders and Business Leaders, Guide, Marketing, omnichannel, Sales
Why sharper specialization, stronger differentiation, and better business development execution now determine who wins. The CRO market continues to grow, but growth will not be distributed evenly. Many biotech CROs have strong science, experienced teams, credible...
